QNRX 8-K: SEC filing

Quoin Pharmaceuticals

Filed with the SEC on Nov 6, 2026 · accession 0001104659-26-123960

QNRX filed a 8-K (current report) with the SEC on Nov 6, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Quoin Pharmaceuticals filed a routine Form 8-K cover page with no substantive corporate event disclosed in the provided text.

For details, click here →How to read a 8-K →

Key details

RegistrantQuoin Pharmaceuticals Ltd.

✦ Ask GOAX AI about this filing — what it means for QNRX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for QNRX?

Click here

Frequently asked questions

What did QNRX file with the SEC on Nov 6, 2026?

QNRX filed a 8-K (SEC filing). Quoin Pharmaceuticals filed a routine Form 8-K cover page with no substantive corporate event disclosed in the provided text.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other QNRX SEC filings

Get alerts when QNRX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

QNRX overview QNRX analysis QNRX news Latest SEC filings